Ensuring Platform Transparency and Accountability
Summary
Open-source investigations and public interest research using platform data (e.g., Facebook, YouTube) have enabled the collection of evidence of human rights atrocities, identified the role of foreign adversaries in manipulating public opinion before elections, and uncovered the prevalence and reach of terrorist radicalization and recruitment tactics. Nascent data privacy legislation such as the EU General Data Protection Regulation and the California Consumer Privacy Act have placed increased pressure on platforms to restrict third party access to data. In an overly cautious interpretation of these laws, platforms are increasingly restricting third-party access to the data they collect. In doing so, platforms shield themselves from public scrutiny and accountability.
To support transparency and accountability of platforms, the next administration should work with Congress to ensure that any new data privacy legislation proposed at the federal level does not inadvertently block the ability of third parties to gain access to platform data for open-source investigations and public interest research. The White House Office of Science and Technology Policy should take the lead by convening a workshop among key actors to make progress on these goals. Out of the workshop, a federal working group should be formed to develop principles and operational guides to support ethical third-party access to platform data, including the formation of technical standards to ensure data privacy and security.
We need a new agency that specializes in uncovering funding opportunities that were overlooked elsewhere. Judging from the history of scientific breakthroughs, the benefits could be quite substantial.
A shift toward more circular, transparent systems would not only reduce waste and increase efficiency, but also unlock new business models, strengthen supply chain resilience, and give consumers better, more reliable information about the products they choose.
By better harnessing the power of data, we can build a learning healthcare system where outcomes drive continuous improvement and where healthcare value leads the way.
In this unprecedented inflection point (and time of difficult disruption) for higher education, science funding, and agency structure, we have an opportunity to move beyond incremental changes and advocate for bold, new ideas that envision a future of the scientific research enterprise that looks very different from the current system.